Ionpath Announces Shift Toward Spatial Proteomics Services Business
MENLO PARK, Calif.--(BUSINESS WIRE)--Ionpath, a pioneer in high-definition spatial proteomics, today announced a rebalancing of the company’s focus toward its Spatial Proteomics Services. The company will suspend sales of its multiplexed ion beam imaging (MIBI™) technology as a standalone platform in favor of using these instruments for its service business....
